Usefulness of Cardiac Magnetic Resonance Imaging to Measure Left Ventricular Wall Thickness for Determining Risk Scores for Sudden Cardiac Death in Patients With Hypertrophic Cardiomyopathy

Echocardiography-derived measurements of maximum left ventricular (LV) wall thickness are important for both the diagnosis and risk stratification of hypertrophic cardiomyopathy (HC). Cardiac magnetic resonance (CMR) imaging is increasingly being used in the assessment of HC; however, little is know...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The American journal of cardiology 2017-05, Vol.119 (9), p.1450-1455
Hauptverfasser: Webb, Jessica, MA, Villa, Adriana, MD, Bekri, Imane, Shome, Joy, MD, Teall, Thomas, MBBS, Claridge, Simon, MBBS, Jackson, Tom, MBBS, Porter, Bradley, MBBS, Ismail, Tevfik F., PhD, Di Giovine, Gabriella, MD, Rinaldi, Christopher A., PhD, Carr-White, Gerald, PhD, Al-Fakih, Khaled, MD, Razavi, Reza, MD, Chiribiri, Amedeo, PhD
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1455
container_issue 9
container_start_page 1450
container_title The American journal of cardiology
container_volume 119
creator Webb, Jessica, MA
Villa, Adriana, MD
Bekri, Imane
Shome, Joy, MD
Teall, Thomas, MBBS
Claridge, Simon, MBBS
Jackson, Tom, MBBS
Porter, Bradley, MBBS
Ismail, Tevfik F., PhD
Di Giovine, Gabriella, MD
Rinaldi, Christopher A., PhD
Carr-White, Gerald, PhD
Al-Fakih, Khaled, MD
Razavi, Reza, MD
Chiribiri, Amedeo, PhD
description Echocardiography-derived measurements of maximum left ventricular (LV) wall thickness are important for both the diagnosis and risk stratification of hypertrophic cardiomyopathy (HC). Cardiac magnetic resonance (CMR) imaging is increasingly being used in the assessment of HC; however, little is known about the relation between wall thickness measurements made by the 2 modalities. We sought to compare measurements made with echocardiography and CMR and to assess the impact of any differences on risk stratification using the current European Society of Cardiology guidelines. Maximum LV wall thickness measurements were recorded on 50 consecutive patients with HC. Sixty-nine percent of LV wall thickness measurements were recorded with echocardiography, compared with 69% from CMR (p
doi_str_mv 10.1016/j.amjcard.2017.01.021
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1875403674</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0002914917301200</els_id><sourcerecordid>1875403674</sourcerecordid><originalsourceid>FETCH-LOGICAL-c495t-1cff6e3bc8d6bd0b9711d1167e0892d2819a9d12d0e0ec723befd665f9b72d6a3</originalsourceid><addsrcrecordid>eNqFksFuEzEQhlcIREvhEUCWuHBJ8HgT7_oCQinQSqlATUuPlteeTZ3s2sH2IuVteBIOPBlOE4rUCyfL9jf_2P8_RfES6Bgo8LersepXWgUzZhSqMYUxZfCoOIa6EiMQUD4ujimlbCRgIo6KZzGu8hZgyp8WR6xmvBK8PC5-XUdsh85hjMS3ZJYFrdLkQi0dJqvJJUbvlNNIznu1tG5JkicXqOIQkMyxTeQbuhSsHjoVyI3qOnJ1a_X6TrD1gZxiwtBbtyu9tHFNFtoH3N8tBmPQ3Tc9RZVuiXXkq0o2q0ZyY_PB2XaDIQW_ybq_f97Bvt_6TYa3z4snreoivjisJ8X1p49Xs7PR_Mvn89mH-UhPxDSNQLctx7LRteGNoY2oAAwAr5DWghlWg1DCADMUKeqKlQ22hvNpK5qKGa7Kk-LNXncT_PcBY5K9jRq7Tjn0Q5TZ9emElryaZPT1A3Tlh-Dy6zJV18AmFaszNd1TOvgYA7ZyE2yvwlYClbuA5UoeApa7gCUFmQPOda8O6kPTo7mv-ptoBt7vAcx2_LAYZNTZTI3GBtRJGm__2-LdAwXd5fy06ta4xfjvNzIySeViN2W7IYOqpMAoLf8AAOjSig</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1888124728</pqid></control><display><type>article</type><title>Usefulness of Cardiac Magnetic Resonance Imaging to Measure Left Ventricular Wall Thickness for Determining Risk Scores for Sudden Cardiac Death in Patients With Hypertrophic Cardiomyopathy</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><source>ProQuest Central UK/Ireland</source><creator>Webb, Jessica, MA ; Villa, Adriana, MD ; Bekri, Imane ; Shome, Joy, MD ; Teall, Thomas, MBBS ; Claridge, Simon, MBBS ; Jackson, Tom, MBBS ; Porter, Bradley, MBBS ; Ismail, Tevfik F., PhD ; Di Giovine, Gabriella, MD ; Rinaldi, Christopher A., PhD ; Carr-White, Gerald, PhD ; Al-Fakih, Khaled, MD ; Razavi, Reza, MD ; Chiribiri, Amedeo, PhD</creator><creatorcontrib>Webb, Jessica, MA ; Villa, Adriana, MD ; Bekri, Imane ; Shome, Joy, MD ; Teall, Thomas, MBBS ; Claridge, Simon, MBBS ; Jackson, Tom, MBBS ; Porter, Bradley, MBBS ; Ismail, Tevfik F., PhD ; Di Giovine, Gabriella, MD ; Rinaldi, Christopher A., PhD ; Carr-White, Gerald, PhD ; Al-Fakih, Khaled, MD ; Razavi, Reza, MD ; Chiribiri, Amedeo, PhD</creatorcontrib><description>Echocardiography-derived measurements of maximum left ventricular (LV) wall thickness are important for both the diagnosis and risk stratification of hypertrophic cardiomyopathy (HC). Cardiac magnetic resonance (CMR) imaging is increasingly being used in the assessment of HC; however, little is known about the relation between wall thickness measurements made by the 2 modalities. We sought to compare measurements made with echocardiography and CMR and to assess the impact of any differences on risk stratification using the current European Society of Cardiology guidelines. Maximum LV wall thickness measurements were recorded on 50 consecutive patients with HC. Sixty-nine percent of LV wall thickness measurements were recorded with echocardiography, compared with 69% from CMR (p &lt;0.001). There was poor agreement on the location of maximum LV wall thickness; weighted-Cohen's κ 0.14 (p = 0.036) and maximum LV wall thicknesses were systematically higher with echocardiography than with CMR (mean 19.1 ± 0.4 mm vs 16.5 ± 0.3 mm, p &lt;0.01, respectively); Bland-Altman bias 2.6 mm (95% confidence interval −9.8 to 4.6). Interobserver variability was lower for CMR (R2 0.67 echocardiography, R2 0.93 CMR). The mean difference in 5-year sudden cardiac death (SCD) risk between echocardiography and CMR was 0.49 ± 0.45% (p = 0.37). When classifying patients (low, intermediate, or high risk), 6 patients were reclassified when CMR was used instead of echocardiography to assess maximum LV wall thickness. These findings suggest that CMR measurements of maximum LV wall thickness can be cautiously used in the current European Society of Cardiology risk score calculations, although further long-term studies are needed to confirm this.</description><identifier>ISSN: 0002-9149</identifier><identifier>EISSN: 1879-1913</identifier><identifier>DOI: 10.1016/j.amjcard.2017.01.021</identifier><identifier>PMID: 28267963</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Adult ; Aged ; Cardiology ; Cardiomyopathy ; Cardiomyopathy, Hypertrophic - complications ; Cardiomyopathy, Hypertrophic - diagnostic imaging ; Cardiomyopathy, Hypertrophic - pathology ; Cardiovascular ; Confidence intervals ; Death, Sudden, Cardiac - epidemiology ; Death, Sudden, Cardiac - etiology ; Echocardiography ; Electrocardiography ; Female ; Health risks ; Heart ; Heart diseases ; Heart Ventricles - diagnostic imaging ; Heart Ventricles - pathology ; Humans ; Magnetic Resonance Imaging ; Magnetic Resonance Imaging, Cine ; Male ; Middle Aged ; NMR ; Nuclear magnetic resonance ; Organ Size ; Patients ; Risk ; Risk Assessment ; Studies ; Task forces ; Thickness measurement ; Ventricle ; Wall thickness</subject><ispartof>The American journal of cardiology, 2017-05, Vol.119 (9), p.1450-1455</ispartof><rights>Elsevier Inc.</rights><rights>2017 Elsevier Inc.</rights><rights>Copyright © 2017 Elsevier Inc. All rights reserved.</rights><rights>Copyright Elsevier Limited May 1, 2017</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c495t-1cff6e3bc8d6bd0b9711d1167e0892d2819a9d12d0e0ec723befd665f9b72d6a3</citedby><cites>FETCH-LOGICAL-c495t-1cff6e3bc8d6bd0b9711d1167e0892d2819a9d12d0e0ec723befd665f9b72d6a3</cites><orcidid>0000-0002-0124-3456</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.proquest.com/docview/1888124728?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995,64385,64387,64389,72469</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28267963$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Webb, Jessica, MA</creatorcontrib><creatorcontrib>Villa, Adriana, MD</creatorcontrib><creatorcontrib>Bekri, Imane</creatorcontrib><creatorcontrib>Shome, Joy, MD</creatorcontrib><creatorcontrib>Teall, Thomas, MBBS</creatorcontrib><creatorcontrib>Claridge, Simon, MBBS</creatorcontrib><creatorcontrib>Jackson, Tom, MBBS</creatorcontrib><creatorcontrib>Porter, Bradley, MBBS</creatorcontrib><creatorcontrib>Ismail, Tevfik F., PhD</creatorcontrib><creatorcontrib>Di Giovine, Gabriella, MD</creatorcontrib><creatorcontrib>Rinaldi, Christopher A., PhD</creatorcontrib><creatorcontrib>Carr-White, Gerald, PhD</creatorcontrib><creatorcontrib>Al-Fakih, Khaled, MD</creatorcontrib><creatorcontrib>Razavi, Reza, MD</creatorcontrib><creatorcontrib>Chiribiri, Amedeo, PhD</creatorcontrib><title>Usefulness of Cardiac Magnetic Resonance Imaging to Measure Left Ventricular Wall Thickness for Determining Risk Scores for Sudden Cardiac Death in Patients With Hypertrophic Cardiomyopathy</title><title>The American journal of cardiology</title><addtitle>Am J Cardiol</addtitle><description>Echocardiography-derived measurements of maximum left ventricular (LV) wall thickness are important for both the diagnosis and risk stratification of hypertrophic cardiomyopathy (HC). Cardiac magnetic resonance (CMR) imaging is increasingly being used in the assessment of HC; however, little is known about the relation between wall thickness measurements made by the 2 modalities. We sought to compare measurements made with echocardiography and CMR and to assess the impact of any differences on risk stratification using the current European Society of Cardiology guidelines. Maximum LV wall thickness measurements were recorded on 50 consecutive patients with HC. Sixty-nine percent of LV wall thickness measurements were recorded with echocardiography, compared with 69% from CMR (p &lt;0.001). There was poor agreement on the location of maximum LV wall thickness; weighted-Cohen's κ 0.14 (p = 0.036) and maximum LV wall thicknesses were systematically higher with echocardiography than with CMR (mean 19.1 ± 0.4 mm vs 16.5 ± 0.3 mm, p &lt;0.01, respectively); Bland-Altman bias 2.6 mm (95% confidence interval −9.8 to 4.6). Interobserver variability was lower for CMR (R2 0.67 echocardiography, R2 0.93 CMR). The mean difference in 5-year sudden cardiac death (SCD) risk between echocardiography and CMR was 0.49 ± 0.45% (p = 0.37). When classifying patients (low, intermediate, or high risk), 6 patients were reclassified when CMR was used instead of echocardiography to assess maximum LV wall thickness. These findings suggest that CMR measurements of maximum LV wall thickness can be cautiously used in the current European Society of Cardiology risk score calculations, although further long-term studies are needed to confirm this.</description><subject>Adult</subject><subject>Aged</subject><subject>Cardiology</subject><subject>Cardiomyopathy</subject><subject>Cardiomyopathy, Hypertrophic - complications</subject><subject>Cardiomyopathy, Hypertrophic - diagnostic imaging</subject><subject>Cardiomyopathy, Hypertrophic - pathology</subject><subject>Cardiovascular</subject><subject>Confidence intervals</subject><subject>Death, Sudden, Cardiac - epidemiology</subject><subject>Death, Sudden, Cardiac - etiology</subject><subject>Echocardiography</subject><subject>Electrocardiography</subject><subject>Female</subject><subject>Health risks</subject><subject>Heart</subject><subject>Heart diseases</subject><subject>Heart Ventricles - diagnostic imaging</subject><subject>Heart Ventricles - pathology</subject><subject>Humans</subject><subject>Magnetic Resonance Imaging</subject><subject>Magnetic Resonance Imaging, Cine</subject><subject>Male</subject><subject>Middle Aged</subject><subject>NMR</subject><subject>Nuclear magnetic resonance</subject><subject>Organ Size</subject><subject>Patients</subject><subject>Risk</subject><subject>Risk Assessment</subject><subject>Studies</subject><subject>Task forces</subject><subject>Thickness measurement</subject><subject>Ventricle</subject><subject>Wall thickness</subject><issn>0002-9149</issn><issn>1879-1913</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNqFksFuEzEQhlcIREvhEUCWuHBJ8HgT7_oCQinQSqlATUuPlteeTZ3s2sH2IuVteBIOPBlOE4rUCyfL9jf_2P8_RfES6Bgo8LersepXWgUzZhSqMYUxZfCoOIa6EiMQUD4ujimlbCRgIo6KZzGu8hZgyp8WR6xmvBK8PC5-XUdsh85hjMS3ZJYFrdLkQi0dJqvJJUbvlNNIznu1tG5JkicXqOIQkMyxTeQbuhSsHjoVyI3qOnJ1a_X6TrD1gZxiwtBbtyu9tHFNFtoH3N8tBmPQ3Tc9RZVuiXXkq0o2q0ZyY_PB2XaDIQW_ybq_f97Bvt_6TYa3z4snreoivjisJ8X1p49Xs7PR_Mvn89mH-UhPxDSNQLctx7LRteGNoY2oAAwAr5DWghlWg1DCADMUKeqKlQ22hvNpK5qKGa7Kk-LNXncT_PcBY5K9jRq7Tjn0Q5TZ9emElryaZPT1A3Tlh-Dy6zJV18AmFaszNd1TOvgYA7ZyE2yvwlYClbuA5UoeApa7gCUFmQPOda8O6kPTo7mv-ptoBt7vAcx2_LAYZNTZTI3GBtRJGm__2-LdAwXd5fy06ta4xfjvNzIySeViN2W7IYOqpMAoLf8AAOjSig</recordid><startdate>20170501</startdate><enddate>20170501</enddate><creator>Webb, Jessica, MA</creator><creator>Villa, Adriana, MD</creator><creator>Bekri, Imane</creator><creator>Shome, Joy, MD</creator><creator>Teall, Thomas, MBBS</creator><creator>Claridge, Simon, MBBS</creator><creator>Jackson, Tom, MBBS</creator><creator>Porter, Bradley, MBBS</creator><creator>Ismail, Tevfik F., PhD</creator><creator>Di Giovine, Gabriella, MD</creator><creator>Rinaldi, Christopher A., PhD</creator><creator>Carr-White, Gerald, PhD</creator><creator>Al-Fakih, Khaled, MD</creator><creator>Razavi, Reza, MD</creator><creator>Chiribiri, Amedeo, PhD</creator><general>Elsevier Inc</general><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7TS</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>M7Z</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-0124-3456</orcidid></search><sort><creationdate>20170501</creationdate><title>Usefulness of Cardiac Magnetic Resonance Imaging to Measure Left Ventricular Wall Thickness for Determining Risk Scores for Sudden Cardiac Death in Patients With Hypertrophic Cardiomyopathy</title><author>Webb, Jessica, MA ; Villa, Adriana, MD ; Bekri, Imane ; Shome, Joy, MD ; Teall, Thomas, MBBS ; Claridge, Simon, MBBS ; Jackson, Tom, MBBS ; Porter, Bradley, MBBS ; Ismail, Tevfik F., PhD ; Di Giovine, Gabriella, MD ; Rinaldi, Christopher A., PhD ; Carr-White, Gerald, PhD ; Al-Fakih, Khaled, MD ; Razavi, Reza, MD ; Chiribiri, Amedeo, PhD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c495t-1cff6e3bc8d6bd0b9711d1167e0892d2819a9d12d0e0ec723befd665f9b72d6a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Cardiology</topic><topic>Cardiomyopathy</topic><topic>Cardiomyopathy, Hypertrophic - complications</topic><topic>Cardiomyopathy, Hypertrophic - diagnostic imaging</topic><topic>Cardiomyopathy, Hypertrophic - pathology</topic><topic>Cardiovascular</topic><topic>Confidence intervals</topic><topic>Death, Sudden, Cardiac - epidemiology</topic><topic>Death, Sudden, Cardiac - etiology</topic><topic>Echocardiography</topic><topic>Electrocardiography</topic><topic>Female</topic><topic>Health risks</topic><topic>Heart</topic><topic>Heart diseases</topic><topic>Heart Ventricles - diagnostic imaging</topic><topic>Heart Ventricles - pathology</topic><topic>Humans</topic><topic>Magnetic Resonance Imaging</topic><topic>Magnetic Resonance Imaging, Cine</topic><topic>Male</topic><topic>Middle Aged</topic><topic>NMR</topic><topic>Nuclear magnetic resonance</topic><topic>Organ Size</topic><topic>Patients</topic><topic>Risk</topic><topic>Risk Assessment</topic><topic>Studies</topic><topic>Task forces</topic><topic>Thickness measurement</topic><topic>Ventricle</topic><topic>Wall thickness</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Webb, Jessica, MA</creatorcontrib><creatorcontrib>Villa, Adriana, MD</creatorcontrib><creatorcontrib>Bekri, Imane</creatorcontrib><creatorcontrib>Shome, Joy, MD</creatorcontrib><creatorcontrib>Teall, Thomas, MBBS</creatorcontrib><creatorcontrib>Claridge, Simon, MBBS</creatorcontrib><creatorcontrib>Jackson, Tom, MBBS</creatorcontrib><creatorcontrib>Porter, Bradley, MBBS</creatorcontrib><creatorcontrib>Ismail, Tevfik F., PhD</creatorcontrib><creatorcontrib>Di Giovine, Gabriella, MD</creatorcontrib><creatorcontrib>Rinaldi, Christopher A., PhD</creatorcontrib><creatorcontrib>Carr-White, Gerald, PhD</creatorcontrib><creatorcontrib>Al-Fakih, Khaled, MD</creatorcontrib><creatorcontrib>Razavi, Reza, MD</creatorcontrib><creatorcontrib>Chiribiri, Amedeo, PhD</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Physical Education Index</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Biochemistry Abstracts 1</collection><collection>Research Library (Corporate)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>The American journal of cardiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Webb, Jessica, MA</au><au>Villa, Adriana, MD</au><au>Bekri, Imane</au><au>Shome, Joy, MD</au><au>Teall, Thomas, MBBS</au><au>Claridge, Simon, MBBS</au><au>Jackson, Tom, MBBS</au><au>Porter, Bradley, MBBS</au><au>Ismail, Tevfik F., PhD</au><au>Di Giovine, Gabriella, MD</au><au>Rinaldi, Christopher A., PhD</au><au>Carr-White, Gerald, PhD</au><au>Al-Fakih, Khaled, MD</au><au>Razavi, Reza, MD</au><au>Chiribiri, Amedeo, PhD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Usefulness of Cardiac Magnetic Resonance Imaging to Measure Left Ventricular Wall Thickness for Determining Risk Scores for Sudden Cardiac Death in Patients With Hypertrophic Cardiomyopathy</atitle><jtitle>The American journal of cardiology</jtitle><addtitle>Am J Cardiol</addtitle><date>2017-05-01</date><risdate>2017</risdate><volume>119</volume><issue>9</issue><spage>1450</spage><epage>1455</epage><pages>1450-1455</pages><issn>0002-9149</issn><eissn>1879-1913</eissn><abstract>Echocardiography-derived measurements of maximum left ventricular (LV) wall thickness are important for both the diagnosis and risk stratification of hypertrophic cardiomyopathy (HC). Cardiac magnetic resonance (CMR) imaging is increasingly being used in the assessment of HC; however, little is known about the relation between wall thickness measurements made by the 2 modalities. We sought to compare measurements made with echocardiography and CMR and to assess the impact of any differences on risk stratification using the current European Society of Cardiology guidelines. Maximum LV wall thickness measurements were recorded on 50 consecutive patients with HC. Sixty-nine percent of LV wall thickness measurements were recorded with echocardiography, compared with 69% from CMR (p &lt;0.001). There was poor agreement on the location of maximum LV wall thickness; weighted-Cohen's κ 0.14 (p = 0.036) and maximum LV wall thicknesses were systematically higher with echocardiography than with CMR (mean 19.1 ± 0.4 mm vs 16.5 ± 0.3 mm, p &lt;0.01, respectively); Bland-Altman bias 2.6 mm (95% confidence interval −9.8 to 4.6). Interobserver variability was lower for CMR (R2 0.67 echocardiography, R2 0.93 CMR). The mean difference in 5-year sudden cardiac death (SCD) risk between echocardiography and CMR was 0.49 ± 0.45% (p = 0.37). When classifying patients (low, intermediate, or high risk), 6 patients were reclassified when CMR was used instead of echocardiography to assess maximum LV wall thickness. These findings suggest that CMR measurements of maximum LV wall thickness can be cautiously used in the current European Society of Cardiology risk score calculations, although further long-term studies are needed to confirm this.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>28267963</pmid><doi>10.1016/j.amjcard.2017.01.021</doi><tpages>6</tpages><orcidid>https://orcid.org/0000-0002-0124-3456</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0002-9149
ispartof The American journal of cardiology, 2017-05, Vol.119 (9), p.1450-1455
issn 0002-9149
1879-1913
language eng
recordid cdi_proquest_miscellaneous_1875403674
source MEDLINE; ScienceDirect Journals (5 years ago - present); ProQuest Central UK/Ireland
subjects Adult
Aged
Cardiology
Cardiomyopathy
Cardiomyopathy, Hypertrophic - complications
Cardiomyopathy, Hypertrophic - diagnostic imaging
Cardiomyopathy, Hypertrophic - pathology
Cardiovascular
Confidence intervals
Death, Sudden, Cardiac - epidemiology
Death, Sudden, Cardiac - etiology
Echocardiography
Electrocardiography
Female
Health risks
Heart
Heart diseases
Heart Ventricles - diagnostic imaging
Heart Ventricles - pathology
Humans
Magnetic Resonance Imaging
Magnetic Resonance Imaging, Cine
Male
Middle Aged
NMR
Nuclear magnetic resonance
Organ Size
Patients
Risk
Risk Assessment
Studies
Task forces
Thickness measurement
Ventricle
Wall thickness
title Usefulness of Cardiac Magnetic Resonance Imaging to Measure Left Ventricular Wall Thickness for Determining Risk Scores for Sudden Cardiac Death in Patients With Hypertrophic Cardiomyopathy
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T03%3A20%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Usefulness%20of%20Cardiac%20Magnetic%20Resonance%20Imaging%20to%20Measure%20Left%20Ventricular%20Wall%20Thickness%20for%20Determining%20Risk%20Scores%20for%20Sudden%20Cardiac%20Death%20in%20Patients%20With%20Hypertrophic%C2%A0Cardiomyopathy&rft.jtitle=The%20American%20journal%20of%20cardiology&rft.au=Webb,%20Jessica,%20MA&rft.date=2017-05-01&rft.volume=119&rft.issue=9&rft.spage=1450&rft.epage=1455&rft.pages=1450-1455&rft.issn=0002-9149&rft.eissn=1879-1913&rft_id=info:doi/10.1016/j.amjcard.2017.01.021&rft_dat=%3Cproquest_cross%3E1875403674%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1888124728&rft_id=info:pmid/28267963&rft_els_id=1_s2_0_S0002914917301200&rfr_iscdi=true